MY127989A - Treatment of neuropathy - Google Patents

Treatment of neuropathy

Info

Publication number
MY127989A
MY127989A MYPI20004933A MY127989A MY 127989 A MY127989 A MY 127989A MY PI20004933 A MYPI20004933 A MY PI20004933A MY 127989 A MY127989 A MY 127989A
Authority
MY
Malaysia
Prior art keywords
treatment
neuropathy
inhibitors
relates
phosphodiesterase type
Prior art date
Application number
Inventor
Nandan Parmanand Koppiker
Steven B Leichter
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY127989A publication Critical patent/MY127989A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THIS INVENTION RELATES TO THE USE OF CYCLIC GUANOSINE 3', 5'- MONOPHOSPHATE PHOSPHODIESTERASE TYPE FIVE (cGMP PDE5) INHIBITORS, INCLUDING IN PARTICULAR THE COMPOUND SILDENAFIL, FOR THE TREATMENT OF NEUROPATHY, INCLUDING IN PARTICULAR THE TREATMENT OF DIABETIC NEUROPATHY.
MYPI20004933 1999-10-21 2000-10-19 Treatment of neuropathy MY127989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9924958.3A GB9924958D0 (en) 1999-10-21 1999-10-21 Treatment of neuropathy

Publications (1)

Publication Number Publication Date
MY127989A true MY127989A (en) 2007-01-31

Family

ID=10863154

Family Applications (2)

Application Number Title Priority Date Filing Date
MYPI20004933 MY127989A (en) 1999-10-21 2000-10-19 Treatment of neuropathy
MYPI20024290 MY138266A (en) 1999-10-21 2000-10-19 Treatment of neuropathy

Family Applications After (1)

Application Number Title Priority Date Filing Date
MYPI20024290 MY138266A (en) 1999-10-21 2000-10-19 Treatment of neuropathy

Country Status (3)

Country Link
GB (1) GB9924958D0 (en)
MY (2) MY127989A (en)
NZ (1) NZ507690A (en)

Also Published As

Publication number Publication date
GB9924958D0 (en) 1999-12-22
MY138266A (en) 2009-05-29
NZ507690A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
EP1129706A3 (en) Use of cGMP PDE5 inhibitors for the treatment of neuropathy
MY135909A (en) Treatment of pulmonary hypertension
HK1027808A1 (en) Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cgmp pde5) for the treatment of sexual dysfunction.
WO2002102314A3 (en) Purine inhibitors of phosphodiesterase (pde) 7
MXPA03005937A (en) Cyclic guanosine 3 ,5 -monophosphate phosphodiesterase inhibitors.
WO2002000657A3 (en) Condensed pyrazindione derivatives
DK1173181T3 (en) Composition comprising inhibitors of phosphodiesterase for the treatment of sexual dysfunction
BR0307410A (en) Use of pde5 inhibitors in the treatment of healing and fibrosis
ZA200205694B (en) Treatment of diabetic ulcers.
MY131573A (en) Use of pde5 inhibitors for the treatment of premature ejaculation
MY127989A (en) Treatment of neuropathy
AU2002234835A1 (en) Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
IL157647A0 (en) INTERMEDIATES FOR PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION